Berberines anti-atherosclerotic efficacy potentially stems from its ability to reduce TMAO production, making it an excellent modulator for inhibiting atherosclerotic plaque development (Chen and Wang, 2021)
If nausea, diarrhea, or abdominal pain emerges, your clinician can reduce your dose, switch you to oral semaglutide, or explore alternatives like tirzepatide
Additionally, these medications act on receptors in the brain's appetite centres, particularly in the hypothalamus, reducing hunger signals and food cravings
15 Further TRIUMPH trials in people with type 2 diabetes and cardiovascular disease are due to be released later in 2026
The pathogenic role of angiogenesis in rheumatoid arthritis